OTCMKTS:VIVXF Avivagen (VIVXF) Stock Price, News & Analysis → Warning: this could blow your mind (From DTI) (Ad) Free VIVXF Stock Alerts $0.0028 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.0028▼$0.002850-Day Range N/A52-Week Range$0.00▼$0.04VolumeN/AAverage Volume1,685 shsMarket Capitalization$213,647.50P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsShort InterestStock AnalysisChartEarningsShort Interest Get Avivagen alerts: Email Address Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> About Avivagen Stock (OTCMKTS:VIVXF)Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.Read More VIVXF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VIVXF Stock News HeadlinesMarch 16, 2023 | businesswire.comAvivagen Inc. Announces Results for the First Quarter Ending January 31, 2023May 30, 2022 | financialpost.comAvivagen Signs New Distribution Partner in Vietnam to Support Southeast Asian GrowthMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 22, 2022 | financialpost.comAvivagen to Attend CEM Sponsored Alpha North ConferenceSee More Headlines Receive VIVXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Next Earnings (Estimated)6/04/2024Fiscal Year End10/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:VIVXF CUSIPN/A CIKN/A Webwww.avivagen.com Phone613-702-2908FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,710,000.00 Net Margins-645.05% Pretax Margin-645.42% Return on EquityN/A Return on Assets-716.72% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.02 Sales & Book Value Annual Sales$730,000.00 Price / Sales0.29 Cash FlowN/A Price / Cash FlowN/A Book Value($0.06) per share Price / Book-0.05Miscellaneous Outstanding Shares77,690,000Free Float76,063,000Market Cap$213,647.50 OptionableNot Optionable Beta0.05 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. G. F. Kym Anthony (Age 68)CEO & Vice Chairman Comp: $267.49kDr. Graham Burton Ph.D.Co-Founder, Chief Scientific Officer & DirectorMr. Ira LevyInterim Chief Financial OfficerDr. James Nickerson Ph.D.President and Executive VP of Business Development & Product InnovationMr. Drew BasekDirector of Investor RelationsMs. Tracy Gillett BVSCDirector of Companion Animal & Marketing ManagerMore ExecutivesKey CompetitorsGelStatOTCMKTS:GSACPresbiaOTCMKTS:LENSFAcura PharmaceuticalsOTCMKTS:ACURPredictive Technology GroupOTCMKTS:PREDSintx TechnologiesNASDAQ:SINTView All Competitors VIVXF Stock Analysis - Frequently Asked Questions How have VIVXF shares performed in 2024? Avivagen's stock was trading at $0.0006 at the beginning of 2024. Since then, VIVXF stock has increased by 358.3% and is now trading at $0.0028. View the best growth stocks for 2024 here. Are investors shorting Avivagen? Avivagen saw a decrease in short interest in the month of February. As of February 29th, there was short interest totaling 24,300 shares, a decrease of 29.2% from the February 14th total of 34,300 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days. View Avivagen's Short Interest. When is Avivagen's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024. View our VIVXF earnings forecast. How do I buy shares of Avivagen? Shares of VIVXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VIVXF) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchAI healthcare stock poised for 36,996% growth?Behind the MarketsMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avivagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.